Third Annual Conference
When: September 28 - 29, 2005
Where: Four Seasons Resort and Club
Dallas at Las Colinas
Hosted by:
CCP Equity Partners
Sponsored by:
CapitalSource Inc.
UBS Investment Bank
Goodwin Procter LLP
Ross & Company,Inc.
Agenda
Wednesday, September 28
12:00 - 7:00 pm Registration
1:00 pm Golf Outing, Shotgun Start(Note new start time)
6:30 pm Cocktails and Dinner
Thursday, September 29
6:30 - 8:00 am Registration & Breakfast
7:30 - 3:30 pm Welcome and Formal Program
CONFERENCE TOPICS
Redefining Healthcare: Creating Value Based Competition on Results," co-authored by Elizabeth Teisberg and Michael Porter, presented by Elizabeth Teisberg
Porter and Teisberg propose a cure for U.S. Healthcare: positive sum competition. This form of competing creates value for healthcare customers - rather than restricting it. By striving to excel at preventing, diagnosing, and treating specific diseases or combinations of conditions, providers can drive up efficiency and effectiveness, reduce errors, and spark innovation.
"How can Public Policy Makers help redefine healthcare?"
"How can Information Vendors support change?"
"What can Employers do?"
"How should Payors and Providers respond?"
SPEAKERS
Presentations by and extensive audience interaction with:
Elizabeth Teisberg, Co-Author, Redefining Health Care
Senator Phil Gramm, Vice Chairman, UBS Investment Bank
Alan Garber, M.D., Ph.D., Director, Center for Health Policy, Stanford University
Jeff Rideout, M.D., Medical Director, Cisco Systems Inc.
John Hammergren, CEO, McKesson Corporation
Woody Myers, M.D., Former EVP and Chief Medical Officer, Wellpoint
C. Martin Harris, M.D., M.B.A., CIO, The Cleveland Clinic Foundation
12:00 Networking Lunch
3:30 Program Adjourns
4:30 Informal Competition
6:30 Cocktails and Dinner
Free afternoon for non golfers.
Please see Four Seasons web site for other resort activities.
Panels and Speakers
Alan Garber, M.D., Ph.D
Henry J. Kaiser, Jr. Professor and Professor of Medicine
Director, Center for Primary Care and Outcomes Research
Director, Center for Health Policy, Stanford University
Senator Phil Gramm
Vice Chairman, UBS Investment Bank
John Hammergren
Chairman and CEO, McKesson Corporation
C. Martin Harris, M.D., M.B.A.
Cheif Information Officer and Chairman,
Information Technology Division, The Cleveland Clinic Foundation (CMS)
Woodrow A. Myers Jr., M.D. M.B.A
Former EVP and Chief Medical Officer,
Healthcare Quality Assurance Division, Wellpoint
Jeff Rideout, M.D., M.A., F.A.C.P.
Vice President, Internet Business Solutions Group
Medical Director, Cisco Systems Inc.
Elizabeth Teisberg
Co-Author, Redefining Health Care - Creating Value Based on Results
Associate Professor of Business Administration,
The Darden School at The University of Virginia
Speaker Biographies
Alan M. Garber is the Henry J. Kaiser Jr. Professor and a Professor of Medicine at Stanford University, where he is also Professor of Economics, Professor of Health Research and Policy, and Professor of Economics in the Graduate School of Business (courtesy). He has been director of both the university’s Center for Health Policy and the Center for Primary Care and Outcomes Research at the School of Medicine since their founding. He is also a Staff Physician at the Veterans Affairs Palo Alto Health Care System, Associate Director of the VA Center for Health Care Evaluation, and Research Associate and Director of the Health Care Program of the National Bureau of Economic Research (NBER).
After graduating from Harvard College summa cum laude, he received his Ph.D. in economics from Harvard and an M.D. with research honors from Stanford, and completed his residency in Medicine at Brigham and Women’s Hospital. He is the recipient of numerous honors and awards, including the Young Investigator Award of the Association for Health Services Research (now AcademyHealth) and the Henry J. Kaiser Family Foundation Faculty Scholarship in General Internal Medicine. He has served as a consultant to the Institute of Medicine, the Congressional Office of Technology Assessment, and the Clinical Efficacy Assessment Project of the American College of Physicians, and as Chair of the Medical and Surgical Procedures Panel of the Medicare Coverage Advisory Committee (Center for Medicare and Medicaid Services). He is a member of the national Blue Cross and Blue Shield Association Medical Advisory Panel and serves as their Scientific Adviser, and a member of the American Society for Clinical Investigation, the Association of American Physicians, the Institute of Medicine of the National Academy of Sciences, and the National Advisory Council on Aging (National Institutes of Health). He is the Chair of the Medicare Coverage Advisory Committee (Centers for Medicare and Medicaid Services).
Dr. Garber’s research is directed toward methods for improving health care delivery and financing, particularly for the elderly, in settings of limited resources. He has developed methods for determining the cost-effectiveness of health interventions, and he studies ways to structure financial and organizational incentives to ensure that cost-effective care is delivered. In addition, his research explores how clinical practice patterns and health care market characteristics influence technology adoption, health expenditures, and health outcomes in the United States and in other countries. He holds an Investigator Award in Health Policy Research from the Robert Wood Johnson Foundation in support of his study of health care productivity, leads the 19-nation Global Healthcare Productivity project, and is Principal Investigator of two centers at Stanford sponsored by the National Institute on Aging: The Center for Demography and Economics of Health and Aging, and the Center on Advancing Decision Making in Aging.
Senator Gramm joined UBS Investment Bank as Vice Chairman in December of 2002 after serving 24 years in Congress, including the last 18 years as Senator from Texas. His role at UBS is focused on providing strategic advice to major corporate clients including government institutions.
The Gramm legislative record includes landmark bills like the Gramm-Latta Budgets, which reduced federal spending, rebuilt national defense and mandated the Reagan tax cut. Two years later he passed his Gramm-Rudman Act, which placed the first binding constraints on federal spending. As Chairman of the National Republican Senatorial Committee, he led the successful effort to restore a Republican majority in the Senate in 1994. As Chairman of the Banking Committee, Senator Gramm steered through legislation modernizing the banking insurance and securities laws, which had been languishing in Congress for 60 years. The Gramm-Leach-Bliley Act repealed the 70-year old Glass-Steagall Act, which prohibited banks securities firms and insurance companies from affiliating. Phil Gramm authored key reforms of the U.S. welfare system and the Homeland Security Act.
U.S. Senator from Texas, elected 1984, 1990, and 1996. Chairman, Committee on Banking, Housing and Urban Affairs; Chairman, Subcommittee on Commerce, Justice, State and the Judiciary of the Senate Appropriations Committee; Chairman, Subcommittee on Health Care of the Senate Committee on Finance; Member, Senate Budget Committee; Member, Senate Committee on Agriculture; Member, Senate Committee on Armed Services.
U.S. Congressman, 6th Congressional District of Texas, elected 1978, 1980 and 1982. Resigned from Congress on January 5, 1983 and re-elected on February 12, 1983 as the first Republican in the history of the 6th Congressional District of Texas (only member of Congress in the 20th Century to resign from Congress and successfully seek re-election as a member of another party.) Member of the Energy and Commerce Committee, Budget Committee and Veterans Affairs Committee.
“Mr. Gramm’s …political career represents the arc of our times. From the policy confusion and economic turmoil of the 1970’s, we have moved to an era of sounder policy and more durable prosperity…Free markets now occupy the moral and policy high ground in America and most of the rest of the world but none of this happened by accident. It required years of policy argument and intellectual conviction by people like Phil Gramm”. - The Wall Street Journal
“…the exemplar of the rule that in the end, ideas count. He sparkles in a Senate that sometimes resembles a hundred blinking yellow lights.” - The National Journal
Phil Gramm holds a Ph.D. from the University of Georgia in economics, the subject he taught at Texas A&M University for 12 years. He has published numerous articles and books on subjects ranging from monetary theory and policy to private property to the economics of mineral extraction.
He is married to Dr. Wendy Lee Gramm, former Chairman of the U.S. Commodity Futures Trading Commission under Presidents Reagan and Bush. They have two sons, Marshall and Jeff.
John H. Hammergren is Chairman and Chief Executive Officer of McKesson Corporation. He has been a director of McKesson since 1999 and was elected President and CEO in 2001 and Chairman in 2002. He has served as President of Supply Management and as Executive Vice President for the pharmaceutical, medical-surgical, pharmacy automation and pharmacy outsourcing businesses of the company. He joined McKesson in January 1996 to lead McKesson Health Systems, a business unit focused on the pharmaceutical supply management needs of healthcare institutions.
Under Hammergren's leadership, McKesson has emerged as the leading provider of supply, information and care management solutions designed to reduce the cost and improve the quality of healthcare. During his tenure, the company has doubled its revenues to $80B, tripled its earnings, expanded into new markets and advanced to no. 15 on the Fortune 500. It has also experienced a cultural transformation driven by the establishment of a set of core values, a commitment to continuous process improvement, and a collaborative approach to serving its customers.
In 2004, Hammergren received the Cap Gemini Ernst & Young Leadership Award for Global Integration and the Warren Bennis Award for Leadership. In addition, he has twice been named one of Modern Healthcare's 100 Most Powerful People in Healthcare. He currently sits on the executive board of Verispan, a healthcare information company and McKesson joint venture.
Prior to joining McKesson, Hammergren led the Medical-Surgical division of Kendall Healthcare Products Company, and held a series of general management positions at Baxter Healthcare Corporation/American Hospital Supply Corporation and Fujisawa Healthcare between 1981 and 1991.
Hammergren earned his bachelor's in Business Administration from the University of Minnesota, and his master's from Xavier University in Cincinnati.
C. Martin Harris, M.D., M.B.A., is the Chief Information Officer and Chairman of the Information Technology Division of The Cleveland Clinic Foundation in Cleveland, Ohio. Additionally, Dr. Harris is Executive Director of e-Cleveland Clinic, a series of e-health clinical programs offered over the Internet.
Dr. Harris’ interest and expertise in the area of improving the practice of medicine through the innovative application of information technology, is reflected in his numerous appointments to national technology organizations including:
- Healthcare Information Technology Advisory Panel, which will serve as the Joint Commission’s principal expert resource on the evolution of the national healthcare infrastructure and the form, direction and speed of information technology adoption in healthcare organizations and related entities.
- Presidential appointment to the Congressional Commission on Systemic Interoperability, which studies the steps required to develop a national health information network
- Chairman, Regional Health Information Organization (RHIO) Task Force of the Healthcare Information and Management Systems Society (HIMSS)
- Past Chairman, Foundation Board for the e-Health Initiative, a public policy and advocacy group established to encourage the interoperability of information technology in healthcare
- Advisor to the Director of the National Institutes of Health
Dr. Harris received his undergraduate and medical degrees from the University of Pennsylvania in Philadelphia. His residency training in general internal medicine was completed at The Hospital of the University of Pennsylvania. He completed a Robert Wood Johnson Clinical Scholar fellowship in General Internal Medicine at The University of Pennsylvania School of Medicine and holds a Masters in Business Administration in Healthcare Management from The Wharton School of the University of Pennsylvania.
Woodrow A. Myers Jr., M.D., M.B.A. served as WellPoint’s executive vice president and chief medical officer from October 2000 through January 2005. Myers managed WellPoint’s Healthcare Quality Assurance Division, which had responsibility for medical policy, clinical affairs and member advocacy. He was also responsible for strategic initiatives designed to enhance the health care experience for the company’s members and to simplify administration and improve communications with physicians and other health care professionals.
Prior to joining WellPoint, Myers served as director of health care management at Ford Motor Company (1996-2000). His responsibilities included the management of quality, cost and access issues related to health benefits, occupational health, workers’ compensation and disability programs.
Before joining Ford, Myers served as corporate medical director for Anthem Blue Cross Blue Shield (1991-1995), and as the commissioner of health for New York City (1990-1991). Myers also served as the commissioner of health for the state of Indiana, and Secretary, Indiana State Board of Health (1985-1990). In the latter part of 1984, he was the physician health advisor, United States Senate Committee on Labor and Human Resources, Washington, D.C.
In the early eighties, Myers served as chairman of San Francisco General Hospital Medical Center’s Quality Assurance Program as well as that hospital’s associate director, for the medical/surgical intensive care unit. Prior to that, he was the physician specialist in surgery and attending physician of the Division of Emergency Services at Stanford University Medical Center.
In April 2005, Myers became a member of the Committee on Assessment of the United State Drug Safety System, appointed by the Institute of Medicine, National Academy of Sciences. In addition, he is a Visiting Professor of Medicine at UCLA School of Medicine, and Vice-Chairman of the Steering Committee on the Future of the King-Drew Medical Center.
Myers is a member of the Institute of Medicine, of the National Academy of Sciences and a Master of the American College of Physicians. He has received numerous medical and community service awards and has published extensively on medical issues important to public health.
Myers’ past teaching and university credentials include assistant professor of medicine at Cornell Medical College, New York City and assistant professor of medicine at the University of California, San Francisco. He is a former adjunct associate professor of medicine, University of Michigan School of Medicine, and former clinical associate professor of medicine at Wayne State University School of Medicine, and Indiana University School of Medicine.
With a Doctor of Medicine (MD) degree from Harvard Medical School, Myers also holds a Masters in Business Administration (MBA) and a Bachelor of Science (BS) from Stanford University Graduate School of Business and Stanford University and is a former Robert Wood Johnson Foundation Clinical Scholar.
As the global leader of Cisco’s Internet Business Solutions Group Healthcare Practice, Dr. Rideout works with health care and public sector leaders to help them use technology to accelerate transformation of the health care industry. Cisco’s IBSG is a group of industry experts that act as a trusted business/technology advisor to business and government leaders around the world. Working on a non-fee basis, the group helps customers use technology and business process innovation to transform their organizations, create new services and drive industry-leading change.
Dr Rideout also serves as Cisco’s Corporate Medical Director. In this role Dr. Rideout provides strategic leadership for health benefit value purchasing decisions for Cisco’s 65,000 employees and dependents worldwide. Dr. Rideout also provides strategic support for business development, investment and policy decisions regarding healthcare for Cisco. In addition, Dr. Rideout is Cisco’s executive representative to the Interoperability Consortium, a collaboration of eight leading technology companies including Accenture, Cisco, CSC, HP, IBM, Intel, Microsoft and Oracle, committed to support the US office of the National Coordinator for HIT’s efforts in creating an interoperable National Health Information Network.
Previously, Dr. Rideout was President and CEO of Blue Shield of California’s independent not for profit charitable foundation dedicated to reducing the uninsured, health care information technology improvement, improving health care access, domestic violence prevention and medical technology assessment. Dr. Rideout was also Chief Medical Officer and SVP for Blue Shield of California. In this role, Dr. Rideout was responsible for all clinical policy and services, including card and disease management, quality management, medical management, medical policy and pharmacy services for Blue Shield of California and its 2.2 million members. Responsibilities also included clinical e-business/e-health programs and strategies, supporting both members and providers. In 2001 Blue Shield of California was recognized by the Blue Cross/Blue Shield Association for two “Best of Blue” innovation awards related to the use of technology for health care quality improvements.
Dr. Rideout is also currently a member of the National Advisory Council for the Robert Wood Johnson/IHI pursuing perfection grant program for excellence in health care delivery. Dr. Rideout also served as the Chief Medical Officer for the National Health Care Purchasing Institute, supporting the institute’s $8.8 million Rewarding Results grant program jointly underwritten by the Robert Wood Johnson Foundation and the California Health Care Foundation. Prior to joining Blue Shield of California, Dr. Rideout served as VP, Quality Improvement, and Associate Chief Medical Officer, for UCSF Stanford Health Care and VP, Quality Management, for Blue Cross of California (now WellPoint).
Dr. Rideout has also worked as a management consultant to several health care focused venture capital and strategic consulting firms, including BDC Advisors, APM, Booz Allen and Hamilton, and Prospect Venture Partners. As a consultant Dr. Rideout has focused on pharmaceutical and medical device marketing, integrated delivery system development, new technology assessment, data systems development and provider system mergers. Dr. Rideout has clinical and administrative experience within the British National Health Service, has provided advice to the SingHealth care delivery “cluster” in Singapore, publishes and speaks regularly on topics related to healthcare quality and information technology, and is also a volunteer physician and Board of Directors member for Northwest Medical Teams International, an international medical relief organization.
Dr. Rideout is a board certified internist, completing his residency training at University of California, San Francisco. He is a Fellow of the American College of Physicians, is an assistant clinical professor at UCSF and a lecturer at the UC Berkeley Haas School of Business. He received his medical degree from Harvard Medical School and his undergraduate degree from Stanford University. He also holds a master’s degree in Philosophy, Politics, and Economics from Oxford University where he studied as a Rhodes Scholar.
Elizabeth Olmsted Teisberg, Associate Professor at the Darden Graduate School of Business at the University of Virginia, is co-author with Michael Porter of the forthcoming book, Redefining Health Care: Creating Value Based Competition to Deliver Value. Previously Drs. Porter and Teisberg published “Redefining Competition in Health Care” in the Harvard Business Review, and “Fixing Competition in U.S. Health Care” as a Harvard Business Review Special Report. Dr. Teisberg’s current research and consulting focus on innovation in health care and in high-technology industries, while her earlier projects have analyzed the strategy in medical device and biotech companies, the real option value of capital investments, research and development decisions, medical innovation, and how managers consider and respond to uncertainty. Previously Dr.Teisberg was a professor in the Strategy Group at the Harvard Business School, worked in management consulting, and as an economist for an international oil company.
Dr. Teisberg is the author or co-author of over 50 articles and cases. Most recently, she published “Redefining Competition in Health Care” in the Harvard Business Review, and “Fixing Competition in U.S. Health Care” as a Harvard Business Review Special Report, both co-authored with Michael E. Porter. Drs. Porter and Teisberg also have a book forthcoming in 2005, Redefining Health Care: Creating Value Based Competition to Deliver Value. More information on this research is available at: http://faculty.darden.virginia.edu/teisberge/healthcare.htm
New Book: Redefining Health Care
In Redefining Health Care, Elizabeth Teisberg and Michael Porter provide solutions to solve the U.S. health care crisis. At stake is the quality of care for millions of Americans and the financial well-being of individuals and employers squeezed by skyrocketing premiums-not to mention the stability of state and federal government budgets.
The authors argue that participants in the health care system have competed to shift costs, accumulate bargaining power, and restrict services, rather than create value for patients. This zero-sum competition takes place at the wrong level-among health plans, networks, and hospitals-rather than where it matters most, in the diagnosis, treatment, and prevention of specific health conditions. Redefining Health Care lays out a breakthrough framework for redefining health care competition based on patient value. With specific recommendations for hospitals, doctors, health plans, employers, and policy makers, this book, and their speaking presentations provide a strategy to move to a positive-sum competition that will unleash stunning improvements in quality and efficiency.